I like that you covered ACI too. Another stem cell company has a partnership deal in MSCs for osteoarthritis and i revisited. OCC again has a superior procedure there too.
As you will know MSCs can become fat cells, cartilidge (chrondyte) cells or bone cells. I had a stem cell procedure from the company in question on a torn labrum (tendon/cartilage mix so ATI not appropriate) and it worked. But in simple terms for pure cartilage issues the MSC cells have to become chrondyte cells whereas OCC you get millions of chrondyte cells ready to go. It's simply more efficient.
Chrondyte and Tenocyte cells cannot become anything else. There is a nagging fear that MSC cells could become encourage cancer cell growth if present. The science gets complicated and debatable, but OCC's procedures are arguably safer by the specific actions therein.
Keep up the good work Pauly. Hope OCC's media consultant starts getting us some more media coverage.
-
- There are more pages in this discussion • 573 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
-0.080(6.13%) |
Mkt cap ! $298.0M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.23 | $1.313M | 1.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4943 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2025 (20 minute delay) ? |
| OCC (ASX) Chart |